IRCT20211122053144N1招募中3 期
Investigating the effects of Silymarin in the treatment of idiopathic hyperbilirubinemia:a randomized,double-blind, placebo-controlled, clinical trial
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 days 至 10 days（—）
- 性别
- All
入选标准
- •Term neonates who have the AAP criteria for the treatment of hyperbilirubinemia with phototherapy
- •Healthy term neonates who have jaundice from the 2nd to the 10th day of birth and need phototherapy
排除标准
- •Neonates with bilirubin level in range of blood exchange
- •The neonate or mother has received phenobarbital
- •Neonates with dehydration, sepsis, pneumonia, anemia, severe weight loss, hypoglycemia, renal failure, heart failure, possible hemolytic or inherited hemolytic disease, neonates with conjugated hyperbilirubinemia, neonates with G6PD, ABO or Rh incompatibility
- •Neonates with a history of jaundice medication from two days before
研究者
相似试验
招募中
3 期
effects of Silymarin in the Prevention of hyperbilirubinemiaeonatal jaundice, unspecified.Neonatal jaundice, unspecifiedP59.9IRCT20231120060123N1Mashhad University of Medical Sciences120
尚未招募
3 期
Effect of silymarin in the treatment of patients with depressioIRCT20160804029191N4Mashhad University of Medical Sciences80
招募中
3 期
Evaluating the effectiveness of Silymarin on the prevention of gentamicin nephrotoxicityGentamicin-induced renal toxicity in hospitalized patients.Other bacterial diseasesA30-A49IRCT20161010030246N3Shiraz University of Medical Sciences60
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60